Highlights of Global Fund TB Projects Implemented by ARFH 2010-2018

The Association for Reproductive and Family Health (ARFH) became the Principal Recipient (PR) for the Global Fund (GF)TB grant in July, 2009 – Dec, 2018. The grant was run in phases. Round 5 Phase 2 TB grant commenced in July 2009 and terminated in June 30th 2010. The SRs under ARFH were; National TB and Leprosy Control Program (NTBLCP) for Drug Susceptible (DS) TB intervention, Institute of Human Virology (IHVN) who was responsible for the Multi-Drug Resistant (MDR) component. Also ILEP partners (GLRA, TLM, NLR), and Health Alive Foundation (HAF) for the community component. Subsequently, under Round-9 phase-1, IHVN became a PR for MDR grant based on the recommendation of the CCM because of their experience with laboratory issues while ARFH remained the PR for Drug Susceptible (DS). Focus of Round 5 & 9 TB grant was on DOT and Microscopy expansion as well as addressing the major challenges with drug management and distribution, while the New Funding Model(2015-2018) was more on ‘’INVESTING FOR IMPACT AGAINST TUBERCULOSIS’’. Highlights of the phases are as shown below.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on whatsapp
WhatsApp
Share on telegram
Telegram
Share on email
Email

Let's engage.

Stay updated

Get notified with updates from ARFH as it happens. Please subscribe now.